stars 1 stars 2 stars 3

Certest Pharma: The pioneering library of ionizable lipids. As experts in advanced LNP technology, our primary focus is developing effective and targeted LNPs for the delivery of next-generation medicines. Our technology, which is available for licensing, covers methods for the development of top-performing proprietary ionizable lipids, optimized LNP compositions and highly robust RNA sequences. Furthermore, our expertise also extends to the design, production and analysis of oligonucleotides in GMP-like quality. Altogether, at Certest Pharma, we provide cutting-edge solutions for every kind of RNA, ranging from just a few tenths of bases to thousands. Where technology and innovation converge, Certest Pharma emerges as a premier provider of lipid-based delivery solutions, with its proprietary ionizable lipids as the cornerstone asset. Certest Pharma is in constant collaboration with multiple partners, including pharmaceutical industries, universities, and other institutions, to enhance global healthcare.

Website https://pharma.certest.es/
Revenue $15.8 million
Employees 28 (21 on RocketReach)
Founded 2021
Industry Biotechnology Research

Certest Pharma Questions

The Certest Pharma annual revenue was $15.8 million in 2026.

Javier Giménez Warren is the CTO of Certest Pharma.

21 people are employed at Certest Pharma.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users